Gene: ADAMTS3
Official Full Name: ADAM metallopeptidase with thrombospondin type 1 motif 3provided by HGNC
Gene Summary: This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protease. This protease, a member of the procollagen aminopropeptidase subfamily of proteins, may play a role in the processing of type II fibrillar collagen in articular cartilage. [provided by RefSeq, Feb 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01636 | ADAMTS3 Knockout cell line (HeLa) | Human | ADAMTS3 | 1:3~1:6 | Negative | Online Inquiry |
KO01637 | ADAMTS3 Knockout cell line (HEK293) | Human | ADAMTS3 | 1:3~1:6 | Negative | Online Inquiry |
ADAMTS3 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to lack the expression of the ADAMTS3 gene, which encodes a member of the ADAMTS (A Disintegrin And Metalloproteinase with Thrombospondin Motifs) family of proteins. These cell lines serve as invaluable tools for elucidating the biological roles of ADAMTS3 in various physiological and pathological processes, including its involvement in tissue remodeling, angiogenesis, and inflammation.
The primary function of the ADAMTS3 protein lies in its ability to regulate extracellular matrix components, influencing cell signaling pathways and modulating the behavior of surrounding cells. By utilizing ADAMTS3 Knockout Cell Lines, researchers can investigate the consequences of the absence of this protein, enabling them to delineate its precise contributions to cellular functions and disease mechanisms. This approach provides critical insights into conditions such as cancer and cardiovascular diseases, where ADAMTS3 may play significant roles.
The scientific importance of these knockout cell lines extends to both basic research and clinical applications. In research settings, they facilitate the study of gene function and the development of therapeutic strategies aimed at targeting ADAMTS3-related pathways. Clinically, understanding the biological mechanisms impacted by ADAMTS3 may offer novel avenues for intervention in disease processes, ultimately enhancing patient outcomes.
One of the key advantages of ADAMTS3 Gene Knockout Cell Lines over traditional research methods is their ability to provide a clean genetic background, allowing for clearer analysis of phenotypic changes attributed solely to the loss of ADAMTS3. Furthermore, these cell lines are rigorously validated, ensuring reliable and reproducible results, which are critical for advancing scientific knowledge and therapeutic innovations.
For researchers and clinicians who seek to deepen their understanding of the molecular underpinnings of various diseases, ADAMTS3 Gene Knockout Cell Lines represent an essential resource in their toolkit. With extensive expertise in genetic engineering and a commitment to quality, our company stands ready to support the scientific community with reliable biological products that drive impactful research outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.